We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Cardiac Hydrogel Delivered by Catheter Speeds Recovery in Porcine Heart Attack Model

By LabMedica International staff writers
Posted on 08 Mar 2012
A hydrogel derived from decellularized heart connective tissue was shown in both rat and porcine models to effectively aid in recovery from damage caused by myocardial infarction (MI).

Investigators at the University of California, San Diego (USA) prepared a novel hydrogel from cardiac connective tissue that was stripped of heart muscle cells through a cleansing process, freeze-dried and milled into powder form, and then liquefied into a fluid. More...
This substance was an injectable liquid at room temperature but turned into a semi-solid, porous gel at body temperature.

Rats were injected with the hydrogel or a saline control two weeks after having experienced induced MI. The implantation response was assessed via histology and immunohistochemistry, and the potential for development of arrhythmias was examined using programmed electrical stimulation one week after the injection. Cardiac function was analyzed with magnetic resonance imaging one week following the injection and four weeks following the MI. In the porcine MI model, the hydrogel was administered via a catheter.

Results published in the February 21, 2012, issue of the Journal of the American College of Cardiology revealed that injection of the material in the rat MI model increased endogenous cardiomyocytes in the infarct area and maintained cardiac function without inducing arrhythmias. Similar results were obtained in the porcine model, which demonstrated the feasibility of treatment by transendocardial catheter injection.

“It helps to promote a positive remodeling-type response, not a pro-inflammatory one in the damaged heart,” said senior author Dr. Karen Christman, professor of bioengineering at the University of California, San Diego. “Most of the materials that people have looked at have been tested in rats or mice, and they are injectable via a needle and syringe. However, almost all of them are not compatible with catheter delivery and would gel too quickly, clogging the catheter during the procedure.”

Related Links:
University of California, San Diego


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
Automated Clinical Chemistry Analyzer
Envoy 500+
New
Portable POCT Blood Gas Analyzer
BD100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers identified 157 metabolites linked to BBB damage, including 25 that appeared in at least two independent studies (Image Credit: Adobe Stock)

Blood Metabolite Patterns May Enable Early Detection of Blood-Brain Barrier Injury

Early injury to the blood-brain barrier (BBB) can precede many neurological disorders but remains difficult to detect noninvasively. Laboratory markers that identify barrier dysfunction before symptoms... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.